BACKGROUND
Antifibrotic therapy slows fibrotic interstitial lung disease (ILD) progression. However, fibrotic ILD remains a major life-threatening condition, with associated morbidity and mortality increasing annually. Growth differentiation factor 15 (GDF15), a stress-responsive cytokine within the transforming growth...
Yuzo Suzuki, Katsuhiro Yoshimura, K. Mori et al.· Respiratory Investigation· 0 citations
Abstract Background Immune checkpoint inhibitors (ICIs) have fundamentally changed cancer treatment, but ICI-related pneumonitis (ICI-P) remains a major clinical concern. Although numerous studies have reported its incidence and risk factors, the retrospective nature of these studies makes accurate assessment difficult...
Yoshihiro Kitahara, Naoki Inui, Takafumi Koyauchi et al.· The Oncologist· 0 citations
OBJECTIVE
Thyroid dysfunction has been increasingly reported after the coronavirus disease 2019 (COVID-19) pandemic. To date, no population-based study has examined this association using more than 10 million matched pairs. We compared the risk of documented thyroid outcomes after COVID-19 with that after influenza dur...
Koichi Miyashita, Kenji Ohba, H. Hozumi et al.· Clinical Endocrinology· 0 citations
BACKGROUND
The clinical significance of filamentous fungi detected from respiratory specimens uncertain in routine clinical practice, particularly for non-Aspergillus. We evaluated longitudinal species distribution and clinical correlates after implementation of MALDI-TOF MS.
METHODS
This single-center retrospective...
Kazuki Furuhashi, Sho Takuma, Osanori Nagura et al.· Journal of Infection and Che...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.